NUNZIA PHARMACEUTICAL Co Quarterly Debt-to-equity in % from Q3 2021 to Q3 2022

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
NUNZIA PHARMACEUTICAL Co quarterly Debt-to-equity history and growth rate from Q3 2021 to Q3 2022.
  • NUNZIA PHARMACEUTICAL Co Debt-to-equity for the quarter ending September 30, 2022 was -114 %, a 7.74% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2022 -114 -8.2 -7.74% Sep 30, 2022
Q2 2022 -110 Jun 30, 2022
Q1 2022 -105 Mar 31, 2022
Q4 2021 -108 Dec 31, 2021
Q3 2021 -106 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.